Plazmaferézis kezelés szisztémás autoimmun betegségekben

Translated title of the contribution: Plasmapheresis treatment in systemic autoimmune disorders

János Jákó, S. Komoly, P. Soltész

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It is necessary to rethink, from time to time, the efficacy of various treatment methods and, consequently, their place in the curing of certain pathological conditions. History of the development of methods throws a light on the fact that it is not always a question to be solved that brings about research; but there are cases when a technique realized for a totally different purpose is being used as a therapeutic process. In autoimmune illnesses, the plasmapheresis therapy is not of recent origin; in spite of that, however, a number of experiences, collected in the treatment of illnesses having divergent pathological symptoms, is not sufficient in itself to establish effectiveness without random double-blind tests. Intervention trying to obtain results under any circumstances (heroic medicine) is to be avoided. When evaluating results in general, however, we must take into consideration the proportion of costs also (cost/benefit principle).

Original languageHungarian
Pages (from-to)72-76
Number of pages5
JournalOrvosi Hetilap
Volume148
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Apr 8 2007

Fingerprint

Plasmapheresis
Cost-Benefit Analysis
Therapeutics
Medicine
Costs and Cost Analysis
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Plazmaferézis kezelés szisztémás autoimmun betegségekben. / Jákó, János; Komoly, S.; Soltész, P.

In: Orvosi Hetilap, Vol. 148, No. SUPPL. 1, 08.04.2007, p. 72-76.

Research output: Contribution to journalArticle

@article{0628896911504359b19a7ae7a9097907,
title = "Plazmafer{\'e}zis kezel{\'e}s sziszt{\'e}m{\'a}s autoimmun betegs{\'e}gekben",
abstract = "It is necessary to rethink, from time to time, the efficacy of various treatment methods and, consequently, their place in the curing of certain pathological conditions. History of the development of methods throws a light on the fact that it is not always a question to be solved that brings about research; but there are cases when a technique realized for a totally different purpose is being used as a therapeutic process. In autoimmune illnesses, the plasmapheresis therapy is not of recent origin; in spite of that, however, a number of experiences, collected in the treatment of illnesses having divergent pathological symptoms, is not sufficient in itself to establish effectiveness without random double-blind tests. Intervention trying to obtain results under any circumstances (heroic medicine) is to be avoided. When evaluating results in general, however, we must take into consideration the proportion of costs also (cost/benefit principle).",
keywords = "Autoimmune diseases, Immunosuppressive therapy, Plasmapheresis",
author = "J{\'a}nos J{\'a}k{\'o} and S. Komoly and P. Solt{\'e}sz",
year = "2007",
month = "4",
day = "8",
doi = "10.1556/OH.2007.28039",
language = "Hungarian",
volume = "148",
pages = "72--76",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Plazmaferézis kezelés szisztémás autoimmun betegségekben

AU - Jákó, János

AU - Komoly, S.

AU - Soltész, P.

PY - 2007/4/8

Y1 - 2007/4/8

N2 - It is necessary to rethink, from time to time, the efficacy of various treatment methods and, consequently, their place in the curing of certain pathological conditions. History of the development of methods throws a light on the fact that it is not always a question to be solved that brings about research; but there are cases when a technique realized for a totally different purpose is being used as a therapeutic process. In autoimmune illnesses, the plasmapheresis therapy is not of recent origin; in spite of that, however, a number of experiences, collected in the treatment of illnesses having divergent pathological symptoms, is not sufficient in itself to establish effectiveness without random double-blind tests. Intervention trying to obtain results under any circumstances (heroic medicine) is to be avoided. When evaluating results in general, however, we must take into consideration the proportion of costs also (cost/benefit principle).

AB - It is necessary to rethink, from time to time, the efficacy of various treatment methods and, consequently, their place in the curing of certain pathological conditions. History of the development of methods throws a light on the fact that it is not always a question to be solved that brings about research; but there are cases when a technique realized for a totally different purpose is being used as a therapeutic process. In autoimmune illnesses, the plasmapheresis therapy is not of recent origin; in spite of that, however, a number of experiences, collected in the treatment of illnesses having divergent pathological symptoms, is not sufficient in itself to establish effectiveness without random double-blind tests. Intervention trying to obtain results under any circumstances (heroic medicine) is to be avoided. When evaluating results in general, however, we must take into consideration the proportion of costs also (cost/benefit principle).

KW - Autoimmune diseases

KW - Immunosuppressive therapy

KW - Plasmapheresis

UR - http://www.scopus.com/inward/record.url?scp=34547665553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547665553&partnerID=8YFLogxK

U2 - 10.1556/OH.2007.28039

DO - 10.1556/OH.2007.28039

M3 - Article

C2 - 17430798

AN - SCOPUS:34547665553

VL - 148

SP - 72

EP - 76

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - SUPPL. 1

ER -